Spy Agent Green Kit is owned by Novadaq Tech.
Spy Agent Green Kit contains Indocyanine Green.
Spy Agent Green Kit has a total of 5 drug patents out of which 0 drug patents have expired.
Spy Agent Green Kit was authorised for market use on 21 November, 2018.
Spy Agent Green Kit is available in powder;intravenous, interstitial dosage forms.
Spy Agent Green Kit can be used as measuring time-varying change in blood in a tissue volume using modified beer-lambert law in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion of vessel with arteriovenous malformation in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion of donor organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; visualization of extrahepatic biliary duct attached to donor organ in patients 12 years and older, visualization of extrahepatic biliary duct attached to transplanted organ in patients 12 years and older; visualization of vessels, blood flow and tissue perfusion of transplanted organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion in surgical flaps in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery.
The generics of Spy Agent Green Kit are possible to be released after 04 August, 2035.
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9421280 | NOVADAQ TECH | Real time imaging during solid organ transplant |
Nov, 2025
(2 years from now) | |
US8185176 | NOVADAQ TECH | Method and apparatus for vasculature visualization with applications in neurosurgery and neurology |
Jun, 2028
(5 years from now) | |
US8647605 | NOVADAQ TECH | Real time imaging during solid organ transplant |
Feb, 2029
(6 years from now) | |
US8406860 | NOVADAQ TECH | Method for evaluating blush in myocardial tissue |
Apr, 2029
(6 years from now) | |
US10631746 | NOVADAQ TECH | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
Aug, 2035
(12 years from now) |
Drugs and Companies using INDOCYANINE GREEN ingredient
Market Authorisation Date: 21 November, 2018
Treatment: Visualization of vessels, blood flow and tissue perfusion of donor organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; Visualization of extrahepatic biliary duct attached to donor organ in patients 12 years and older; Visualization of vessels, blood flow and tissue perfusion of vessel with arteriovenous malformation in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; Visualization of extrahepatic biliary duct attached to transplanted organ in patients 12 years and older; Visualization of vessels, blood flow and tissue perfusion of transplanted organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; Visualization of vessels, blood flow and tissue perfusion in surgical flaps in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; Measuring time-varying change in blood in a tissue volume using modified beer-lambert law in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery
Dosage: POWDER;INTRAVENOUS, INTERSTITIAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic